2020201920182017201620152014 March 22, 2018 Summary ToggleSpero Therapeutics to Present at Upcoming Investor Conferences March 01, 2018 Summary ToggleSpero Therapeutics to Present at March Investor Conferences February 01, 2018 Summary ToggleSpero Announces Appointment of David P. Southwell to its Board of Directors January 04, 2018 Summary ToggleSpero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer December 14, 2017 Summary ToggleSpero Therapeutics Announces 3Q17 Operating Results and Pipeline Update November 13, 2017 Summary ToggleSpero Therapeutics Announces Underwriters’ Option Exercise November 06, 2017 Summary ToggleSpero Therapeutics Announces Closing of Initial Public Offering November 01, 2017 Summary ToggleSpero Therapeutics Announces Pricing of Initial Public Offering October 23, 2017 Summary ToggleSpero Therapeutics Launches Initial Public Offering October 20, 2017 Summary ToggleSpero Therapeutics Initiates Clinical Program For Oral Carbapenem SPR994 Pagination First page First Previous page Previous … Page 7 Current page 8 Page 9 Page 10 … Next page Next Last page Last
